Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
The French biotech firm Enterome has signed deals with two big pharma companies to develop drugs derived from the gut microbiome. Enterome will work with Johnson & Johnson’s Janssen Biotech unit to discover targets and bioactive molecules related to Crohn’s disease. With Takeda Pharmaceutical it will research and develop drugs directed at microbiome targets involved with gastrointestinal disorders. In both deals Enterome is eligible for up-front payments plus research funding.
This article has been sent to the following recipient: